Figure 5.
A, B, Plasma severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) anti-spike antibody levels, measured in light units (LUs), are correlated with nasal (A) and saliva (B) anti-spike antibody levels in unvaccinated infected persons. C, D, Nasal SARS-CoV-2 anti-spike antibody is correlated with saliva anti-spike antibody (C), and plasma anti-spike antibody with nasal immunoglobulin (Ig) A anti-spike antibody (D) in unvaccinated infected persons. Data points represent results for individual participants (22 participants in A and C, 23 in B, and 21 in D), and vertical dotted lines represent cutoff levels for a positive plasma anti-spike antibody assay result.
